See also this year's filing and all EDGAR filings for this company.
PDF Report 0000744218_2019_Celldex_Therapeutics_Inc.pdf
Logs
info | NetIncome node detected by tax heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'NetIncomeLossAvailableToCommonStockholdersBasic'} |
Graph
Absolute values for 0000744218, Celldex Therapeutics Inc.
xvar | xval | |
---|---|---|
0 | LiabilitiesNoncurrent | 19,147,000 |
1 | LiabilitiesCurrent | 12,602,000 |
2 | remainder_Liabilities | 0 |
3 | AssetsCurrent | 99,079,000 |
4 | AssetsNoncurrent | 1,929,000 |
5 | PropertyPlantAndEquipmentNet | 6,111,000 |
6 | Goodwill | 48,690,000 |
7 | remainder_Assets | 0 |
8 | GeneralAndAdministrativeExpense | 19,269,000 |
9 | ResearchAndDevelopmentExpense | 66,449,000 |
10 | remainder_Expenses | 79,491,000 |
11 | remainder_Revenues | 14,025,000 |
12 | remainder_NetIncome | 0 |
13 | remainder_ComprehensiveNetIncome | 19,000 |
yvar | yval | |
---|---|---|
0 | Liabilities | 31,749,000 |
1 | Assets | 155,809,000 |
2 | Expenses | 165,209,000 |
3 | Revenues | 14,025,000 |
4 | StockholdersEquity | 124,060,000 |
5 | NetIncome | -151,184,000 |
6 | ComprehensiveNetIncome | -151,174,500 |
7 | BaseVar | 183,405,500 |
8 | EconomicCapitalRatio | -0.488 |